These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10052971)

  • 21. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects.
    Matsushita N; Aritake K; Takada A; Hizue M; Hayashi K; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H
    Jpn J Pharmacol; 1998 Sep; 78(1):11-22. PubMed ID: 9804057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration.
    Kuss H; Hoefgen N; Johanssen S; Kronbach T; Rundfeldt C
    J Pharmacol Exp Ther; 2003 Oct; 307(1):373-85. PubMed ID: 12944497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-carnitine does not exert any in vitro relaxant effect in Guinea pig trachea, lung parenchyma and human bronchial tissue.
    Uzuner N; Kavukcu S; Karaman O; Apaydin S; Göldeli E
    Exp Lung Res; 2002 Sep; 28(6):485-92. PubMed ID: 12217214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
    Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
    J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.
    Lorrain DS; Bain G; Correa LD; Chapman C; Broadhead AR; Santini AM; Prodanovich P; Darlington JV; Hutchinson JH; King C; Lee C; Baccei C; Li Y; Arruda JM; Evans JF
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1042-50. PubMed ID: 19749079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New esters of heteryl acetic and mercaptoacetic acids. Synthesis and H1-antihistaminic evaluation.
    Rao AR; Reddy VM
    Arzneimittelforschung; 1993 Jun; 43(6):663-7. PubMed ID: 8102528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti type I allergic property of Japanese butterbur extract and its mast cell degranulation inhibitory ingredients.
    Shimoda H; Tanaka J; Yamada E; Morikawa T; Kasajima N; Yoshikawa M
    J Agric Food Chem; 2006 Apr; 54(8):2915-20. PubMed ID: 16608208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.
    Bundschuh DS; Eltze M; Barsig J; Wollin L; Hatzelmann A; Beume R
    J Pharmacol Exp Ther; 2001 Apr; 297(1):280-90. PubMed ID: 11259555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergic sensitization enhances the contribution of Rho-kinase to airway smooth muscle contraction.
    Schaafsma D; Gosens R; Bos IS; Meurs H; Zaagsma J; Nelemans SA
    Br J Pharmacol; 2004 Oct; 143(4):477-84. PubMed ID: 15381630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
    Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM
    J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Rho-kinase normalizes nonspecific hyperresponsiveness in passively sensitized airway smooth muscle preparations.
    Schaafsma D; Zuidhof AB; Nelemans SA; Zaagsma J; Meurs H
    Eur J Pharmacol; 2006 Feb; 531(1-3):145-50. PubMed ID: 16451800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiallergic activity of a disaccharide isolated from Sanguisorba officinalis.
    Park KH; Koh D; Kim K; Park J; Lim Y
    Phytother Res; 2004 Aug; 18(8):658-62. PubMed ID: 15472918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory and smooth muscle relaxant activities of the hydroalcoholic extract and chemical constituents from Amburana cearensis A C Smith.
    Leal LK; Nechio M; Silveira ER; Canuto KM; Fontenele JB; Ribeiro RA; Viana GS
    Phytother Res; 2003 Apr; 17(4):335-40. PubMed ID: 12722135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Animal studies supporting the inhibition of mast cell activation by Eriobotrya japonica seed extract.
    Onogawa M; Sun G; Takuma D; Hamada A; Yokota J; Yoshioka S; Kusunose M; Miyamura M; Kyotani S; Nishioka Y
    J Pharm Pharmacol; 2009 Feb; 61(2):237-41. PubMed ID: 19178772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one].
    Boswell-Smith V; Spina D; Oxford AW; Comer MB; Seeds EA; Page CP
    J Pharmacol Exp Ther; 2006 Aug; 318(2):840-8. PubMed ID: 16682455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.
    Leopoldo M; Lacivita E; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2007 Aug; 50(17):4214-21. PubMed ID: 17649988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological activities of novel antiallergic agents with 5-lipoxygenase inhibiting action.
    Nakano H; Inoue T; Kawasaki N; Miyataka H; Matsumoto H; Taguchi T; Inagaki N; Nagai H; Satoh T
    Bioorg Med Chem; 2000 Feb; 8(2):373-80. PubMed ID: 10722160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological evaluation of perhydropyrrolo [3,4-c]pyridine derivatives.
    Altomare C; Carotti A; Casini G; Cellamare S; Ferappi M; Brigiani GS; Persichella M
    Farmaco; 1990 May; 45(5):489-97. PubMed ID: 1977402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
    Strub A; Ulrich WR; Hesslinger C; Eltze M; Fuchss T; Strassner J; Strand S; Lehner MD; Boer R
    Mol Pharmacol; 2006 Jan; 69(1):328-37. PubMed ID: 16223957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.